Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas

British Journal of Cancer

Volumn 96, Issue 12, 2007, Pages 1908-1913

  Yu, J ^a   Roy, D ^a   Brockmeyer, A D ^a   Dubeau, L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Aneuploidy; Cellular aging; Chromosomal stability; Ovarian neoplasms; Telomeres

Indexed keywords

DNA; VIRUS LARGE T ANTIGEN;

ARTICLE; CELL CULTURE; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; CYSTADENOMA; DIPLOIDY; DISEASE PREDISPOSITION; HUMAN; HUMAN CELL; IN VIVO STUDY; MORTALITY; OVARY TUMOR; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS 40; TELOMERE; TUMOR GROWTH;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE, TUMOR; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; CYSTADENOMA; DNA, NEOPLASM; FEMALE; GENETIC VECTORS; HUMANS; OVARIAN NEOPLASMS; PLOIDIES; TELOMERE;

EID: 34250322522     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603817     Document Type: Article

References (30)

1. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641-645, doi:10.1038/35020592
2. Aure JC, Hoeg K, Kolstad P (1971) Clinical and histologic studies of ovarian carcinoma: long-term follow-up of 990 cases. Obstet Gynecol 37: 1-9
3. Buick RN, Pullano R, Trent JM (1985) Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45: 3668-3676
4. Burger CW, Prinssen HM, Baak JPA, Wagenaar N, Kenemans P (2000) The management of borderline epithelial tumors of the ovary. Int J Gynecol Cancer 10: 181-197, doi:10.1046/j.1525-1438.2000.010003181.x
5. Cheng EJ, Kurman RJ, Wang M, Oldt III R, Berman DM, Shih I-M (2004) Molecular genetic analysis of ovarian serous cystadenomas. Lab Invest 84: 778-784, doi:10.1038/labinvest.3700103
6. Cheng PC, Gosewehr J, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela B, Godorov G, Dubeau L (1996) Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst 88: 510-518
7. Cheng PC, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L (1997) Alterations in DNA methylation are early, but not initial events in ovarian tumorigenesis. Br J Cancer 75: 396-402
8. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929
9. Friedlander ML, Russell P, Taylor IW, Hedley DW, Tattersall MH (1984) Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology 16: 301-306
10. Hara E, Tsurui H, Shinozaki A, Nakada S, Oda K (1991) Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun 179: 528-534, doi:10.1016/0006-291X(91)91403-Y
11. Ho C-L, Kurman RJ, Dehari R, Wang T-L, Shih I-M (2004) Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors. Cancer Res 64: 6915-6918
12. Kaern J, Trope CG, Kjorstad KE, Abeler VM, Pettersen EO (1990) Cellular DNA content as a new prognostic tool in patients with tumors of the ovary. Gynecol Oncol 38: 452-457, doi:10.1016/0090-8258(90)90090-8
13. Kurman RJ, Trimble CL (1993) The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 12: 120-127
14. Lai CH, Hsueh S, Chang TC (1996) The role of DNA cytoflowmetry in borderline malignant ovarian tumors. Cancer 78: 794-802
15. Luo MP, Gomperts B, Imren S, DeClerck YA, Ito M, Velicescu M, Felix JC, Dubeau L (1997) Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases. Gynecol Oncol 67: 277-284, doi:10.1006/gyno.1997.4880
16. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW (1993) Mutation of k-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 53: 1489-1492
17. O'Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin L, DePinho RA (2002) Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2: 149-155, doi:10.1016/S1535/6108(02) 00094-6
18. Qu G, Dubeau L, Narayan A, Yu MC, Ehrlich M (1999) Satellite DNA hypomethylation vs overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat Res 423: 91-101
19. Santesson L, Kottmeier HL (1968) General classification of ovarian tumors. In: UICC Monograph Series. Ovarian Cancer, Gentils F and Junqueira AC (eds). New York: Springer-Verlag
20. Seidman JD, Ronnett BM, Kurman RJ (2002) Pathology of borderline (low malignant potential) ovarian tumours. Best Pract Res Clin Obstet Gynaecol 16: 499-512, doi:10.1053/beog.2002.0300
21. Serov SF, Scully RE, Sobin LH (1973) Histological typing of ovarian tumors. In International Histological Classification of Tumours, No 9: Geneva: World Health Organization
22. Shay JW, Pereira-Smith OM, Wright W (1991) A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196: 33-39, doi:10.1016/0014-4827(91)90453-2
23. Shih IM, Kurman RJ (2005) Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 11: 7273-7379
24. Sykes PH, Quinn MA, Rome RM (1997) Ovarian tumors of low malignant potential: a retrospective study of 234 patients. Int J Gynecol Cancer 7: 218-226, doi:10.1046/j.1525-1438.1997.00445.x
25. Taylor JHC (1929) Malignant and semimalignat tumors of the ovary. Surg Gynecol Obstet 48: 204-208
26. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ (1993) p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53: 3103-3108
27. Velicescu M, Yu J, Herbert B-S, Shay JW, Granada E, Dubeau L (2003) Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells. Cancer Res 63: 5813-5820
28. Wan M, Li W-Z, Duggan B, Felix J, Zhao Y, Dubeau L (1997) Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst 89: 437-441, doi:10.1093/jnci/89.6.437
29. Zheng J, Benedict WF, Xu H-J, Hu S-X, Kim TM, Velicescu M, Wan M, Cofer KF, Dubeau L (1995) Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J Natl Cancer Inst 87: 1146-1153, doi:10.1093/jnci/87.15.1146
30. Zheng J, Wan M, Zweizig S, Velicescu M, Yu MC, Dubeau L (1993) Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Cancer Res 53: 4138-4142